CoCo Therapeutics Ltd. Formed to Advance Development of Alzheimer's Drug

Date: 01 April 2013


CoCo Therapeutics Ltd. was founded upon the successful collaboration between King’s College London, The Wellcome Trust and Advent Venture Partners to advance an Alzheimer's drug candidate to late stage clinical trials. The company's has developed CNS brain-penetrable RAR-alpha agonists effecting a crucial pathway thought to be involved in Alzheimer's development.


Announcement web link

Contact Name: Lloyd Dunlap

Contact E-mail: